Literature DB >> 4855449

3Alpha-androstanediol kinetics in man.

T Kinouchi, R Horton.   

Abstract

Kinetics of 5alpha-androstane-3alpha, 17beta-diol (3alpha-diol) were studied in man. Clearance rates were determined by both the constant infusion and single injection techniques. Production rates were calculated as the product of clearance rate data and plasma values in the a.m. obtained by a radioimmunoassay specific for 3alpha-diol. Mean metabolic clearance rates were 1,776+/-492 (SD) liters/day in males and 1,297+/-219 (SD) liters/day in females. Metabolic clearance rates by single injection were similar. Calculated production rates are 208+/-26 (SD) mug/day in males and 35+/-11 mug/day in females, which are significantly different. Hepatic extraction of 3alpha-diol determined by hepatic vein catheterization during constant infusion was 76% which was greater than expected from information on in vitro binding in plasma. The kinetic data is of interest since 3alpha-diol has a calculated inner pool (V(1)) volume of 12-14 liters, similar to 17beta-hydroxyandrost-4-en-3-one (testosterone) and 5alpha-androstan-17beta-ol-3-one (dihydrotestosterone), but the calculated outer pool (V(2)) of 33.5 liters is very large as are the metabolic rate and transfer constant. In contrast to testosterone and dihydrotestosterone, 3alpha-diol, although bound to sex hormone binding globulin, has a high metabolic clearance of which a large fraction represents extrahepatic (splanchnic) metabolism. A production rate of 3alpha-diol similar to dihydrotestosterone together with rather unique kinetic characteristics encourages further investigation of the biological role of this potent androgen.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4855449      PMCID: PMC301598          DOI: 10.1172/JCI107802

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  STUDIES ON THE SECRETION AND INTERCONVERSION OF THE ANDROGENS.

Authors:  R L VANDEWIELE; P C MACDONALD; E GURPIDE; S LIEBERMAN
Journal:  Recent Prog Horm Res       Date:  1963

2.  The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects.

Authors:  J F TAIT; S A TAIT; B LITTLE; K R LAUMAS
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

3.  In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.

Authors:  R Horton; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

4.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

Review 5.  Steroid dynamics under steady-state conditions.

Authors:  D T Baird; R Horton; C Longcope; J F Tait
Journal:  Recent Prog Horm Res       Date:  1969

6.  Dihydrotestosterone in human peripheral plasma.

Authors:  T Ito; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1970-10       Impact factor: 5.958

7.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

8.  Splanchnic extraction and interconversion of testosterone and androstenedione in man.

Authors:  M A Rivarola; R T Singleton; C J Migeon
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  TESTOSTERONE PRODUCTION AND METABOLIC CLEARANCE RATES WITH VOLUMES OF DISTRIBUTION IN NORMAL ADULT MEN AND WOMEN.

Authors:  R HORTON; J SHINSAKO; P H FORSHAM
Journal:  Acta Endocrinol (Copenh)       Date:  1965-03

10.  Conversion of blood androgens to estrogens in normal adult men and women.

Authors:  C Longcope; T Kato; R Horton
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  6 in total

1.  Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.

Authors:  James L Mohler; Mark A Titus; Suxia Bai; Brian J Kennerley; Fred B Lih; Kenneth B Tomer; Elizabeth M Wilson
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

2.  Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes.

Authors:  M S Mahendroo; K M Cala; D L Hess; D W Russell
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

3.  3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.

Authors:  R Horton; D Hawks; R Lobo
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

Review 4.  Pre-receptor regulation of the androgen receptor.

Authors:  Trevor M Penning; Yi Jin; Tea Lanisnik Rizner; David R Bauman
Journal:  Mol Cell Endocrinol       Date:  2007-10-22       Impact factor: 4.102

5.  Circulating dihydrotestosterone may not reflect peripheral formation.

Authors:  V Toscano; R Horton
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.

Authors:  I Morimoto; A Edmiston; R Horton
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.